Data spanning the past 90 days through February 07, 2026 reveals that Altimmune's three principal insider shareholders consist of Director Vipin K Garg (424.52K shares), Chief Scientific Officer M Scot Roberts (112.82K shares), Director David Drutz (75.67K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Vipin K Garg | 424,519 | 02 Feb, 2026 | |
| M Scot Roberts | Chief Scientific Officer | 112,824 | 03 Feb, 2026 |
| David Drutz | 75,675 | 21 Nov, 2022 | |
| Raymond M Jordt | Chief Business Officer | 70,107 | 02 Feb, 2026 |
| Richard I Eisenstadt | Chief Financial Officer | 45,012 | 01 Feb, 2024 |
| Gregory L Weaver | Chief Financial Officer | 23,078 | 12 Nov, 2025 |
| William Michael Brown | Chief Financial Officer | 17,721 | 06 Aug, 2021 |
| Matthew Scott Harris | Chief Medical Officer | 16,087 | 04 Aug, 2025 |
| Wayne Pisano | 13,498 | 09 Jan, 2026 | |
| Jerome Benedict Durso | 12,500 | 22 Dec, 2025 | |
| John Gill | 12,500 | 23 Dec, 2025 | |
| Andrew Shutterly | Acting Chief Financial Officer | 11,372 | 01 Aug, 2024 |
| Klaus Schafer | 9,179 | 22 Jun, 2022 | |
| Catherine A. Sohn | 1,500 | 05 Jan, 2026 | |
| Diane Jorkasky | 527 | 29 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | D | 2,329 | $5.55 | 112,824 | D | F |
| 02 Feb, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | A | 7,775 | $0.00 | 115,153 | D | M |
| 31 Jan, 2026 | Vipin K Garg | Common Stock, par value $0.0001 | A | 6,926 | $3.07 | 424,519 | D | A |
| 31 Jan, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | A | 5,567 | $3.07 | 107,378 | D | A |
| 31 Jan, 2026 | Raymond M Jordt | Common Stock, par value $0.0001 | A | 4,571 | $3.07 | 70,107 | D | A |
| 30 Jan, 2026 | Vipin K Garg | Common Stock, par value $0.0001 | A | 26,775 | $0.00 | 429,225 | D | M |
| 30 Jan, 2026 | Vipin K Garg | Common Stock, par value $0.0001 | D | 11,632 | $5.60 | 417,593 | D | F |
| 30 Jan, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | A | 9,275 | $0.00 | 104,670 | D | M |
| 30 Jan, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | D | 2,859 | $5.60 | 101,811 | D | F |
| 27 Jan, 2026 | Vipin K Garg | Common Stock, par value $0.0001 | D | 17,898 | $6.18 | 402,450 | D | F |
| 27 Jan, 2026 | Vipin K Garg | Common Stock, par value $0.0001 | A | 41,200 | $0.00 | 420,348 | D | M |
| 27 Jan, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | A | 15,850 | $0.00 | 100,143 | D | M |
| 27 Jan, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | D | 4,748 | $6.18 | 95,395 | D | F |
| 27 Jan, 2026 | Raymond M Jordt | Common Stock, par value $0.0001 | D | 4,229 | $6.18 | 65,536 | D | F |
| 27 Jan, 2026 | Raymond M Jordt | Common Stock, par value $0.0001 | A | 15,850 | $0.00 | 69,765 | D | M |
| 25 Jan, 2026 | Vipin K Garg | Common Stock, par value $0.0001 | A | 42,050 | $0.00 | 397,132 | D | M |
| 25 Jan, 2026 | Vipin K Garg | Common Stock, par value $0.0001 | D | 17,984 | $5.50 | 379,148 | D | F |
| 25 Jan, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | A | 14,600 | $0.00 | 88,666 | D | M |
| 25 Jan, 2026 | M Scot Roberts | Common Stock, par value $0.0001 | D | 4,373 | $5.50 | 84,293 | D | F |
| 25 Jan, 2026 | Raymond M Jordt | Common Stock, par value $0.0001 | A | 14,600 | $0.00 | 57,770 | D | M |